Author:
Chaudhuri Jasodhara,Biswas Tamoghna,Ganguly Gautam,Datta Supratim,Pandit Alak,Biswas Atanu
Publisher
Springer Science and Business Media LLC
Subject
Clinical Neurology,General Medicine
Reference15 articles.
1. Ramanathan S, Dale RC, Brilot F (2016) Anti-MOG antibody: the history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination. Autoimmun Rev 15(4):307–324. https://doi.org/10.1016/j.autrev.2015.12.004
2. Duignan S, Wright S, Rossor T, Cazabon J, Gilmour K, Ciccarelli O et al (2018) Myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies are highly specific in children with acquired demyelinating syndromes. Dev Med Child Neurol 60(9):958–962. https://doi.org/10.1111/dmcn.13703
3. Dos Passos GR, Oliveira LM, da Costa BK et al (2018) MOG-IgG-associated optic neuritis, encephalitis, and myelitis: lessons learned from neuromyelitis optica spectrum disorder. Front Neurol 9:217
4. Pandit L, Mustafa S, Nakashima I, Takahashi T, Kaneko K (2018) MOG-IgG-associated disease has a stereotypical clinical course, asymptomatic visual impairment and good treatment response. Mult Scler J Exp Transl Clin 4(3):2055217318787829
5. Reindl M, Waters P (2019) Myelin oligodendrocyte glycoprotein antibodies in neurological disease. Nat Rev Neurol 15(2):89–102
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献